|
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
|
-
Human medicines European Public Assessment Report (EPAR): Tasmar, tolcapone, Revision: 14, Authorised
-
Human medicines European Public Assessment Report (EPAR): Avastin, bevacizumab, Revision: 25, Authorised
-
Human medicines European Public Assessment Report (EPAR): Docetaxel Winthrop, docetaxel, Revision: 11, Authorised
-
Human medicines European Public Assessment Report (EPAR): Gilenya, fingolimod, Revision: 2, Authorised
-
Human medicines European Public Assessment Report (EPAR): Evista, raloxifene, Revision: 17, Authorised
|
Feeds lajmesh